Benzinga's Top #PreMarket Gainers
September 26, 2014 at 08:02 AM EDT
Repros Therapeutics (NASDAQ: RPRX) shares jumped 15.51% to $10.35 in pre-market trading following the announcement that Androxal ZA-304 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|